FluxMPS™ Leibovitz's L-15
FluxMPS™ DCP-LL15H-P2X is an MPS-grade, ultra-filtered Leibovitz's L-15 2X + 50mM HEPES formulation engineered for Primary cells and related cell models on organ-on-a-chip (OoC) and microphysiological system (MPS) platforms. Processed through a Quadruple-stage filtration system (0.1 µm ×2 + 0.04 µm ×2), it delivers approximately 5× lower particulate counts than conventional 0.22 µm–filtered media. HEPES (50 mM, pKa 7.3 at 37°C) provides robust pH buffering. Formulation: [+] 1.8 g/L D-Galactose, [+] L-Glutamine, [+] 50mM HEPES | [-] Sodium Pyruvate.
- CO₂-free by design: D-galactose energy source + high amino acid buffering — no gas supplementation required
- 50 mM HEPES (pKa 7.3 at 37°C) — robust pH buffering independent of CO₂
- 0.04 µm final nano-filtration — sub-mycoplasma purity; < 0.05 EU/mL endotoxin
- Quadruple-stage filtration: 0.1 µm pre-I → 0.04 µm pre-II → 0.1 µm sterile-I → 0.04 µm final polish
- Ultrapure Type 1 water (18.2 MΩ·cm), ISO 13485:2016 QMS, ISO Class 5 fill
- Media familyLeibovitz's L-15 2X + 50mM HEPES
- Carbon (Galactose)1800 mg/L (1.8 g/L, D-Galactose)
- HEPES50 mM, pKa 7.3 at 37°C
- Formulation[+] 1.8 g/L D-Galactose, [+] L-Glutamine, [+] 50mM HEPES | [-] Sodium Pyruvate
- AppearanceOrange-Red colored, clear solution
- pH (USP <791>)7.4
- Osmolality (USP <785>)Contact for specification
- Endotoxin (USP <85>)< 0.05 EU/mL
- Filtration0.1 µm ×2 + 0.04 µm ×2
- Shelf Life12 months / 2–8°C
Engineered where standard media fails
Conventional 0.22 µm–filtered Leibovitz's passes mycoplasma, subvisible particulates, and endotoxin fragments that interfere with CO₂-free pH maintenance and live imaging clarity. FluxMPS™ eliminates these failure modes.
Microchannel-safe purity
0.04 µm final filtration; USP <788> particulate compliance. Particle-free L-15 for clear live imaging and CO2-free chip loading.
CO₂-free by design formulation
Leibovitz's L-15 uses D-galactose (not glucose) as the primary carbon source and high amino acid concentrations for CO₂-free pH buffering. This is a 2X concentrated formulation. 50 mM HEPES provides e
Ultrapure-grade water
18.2 MΩ·cm — eliminates ionic contaminants that interfere with L-15 amino acid buffering capacity.
Below TLR4 endotoxin threshold
< 0.05 EU/mL — prevents LPS-driven inflammatory activation in primary cells.
HEPES pH stability
HEPES (50 mM) prevents pH rise during open-air handling, flow cytometry preparation, and atmospheric incubation.
Customization on demand
pH, nutrient concentrations, HEPES, and component modifications available. Contact support@diagnocine.com.
Quadruple-stage filtration system
Four serial filtration stages reaching a final 0.04 µm polish under ISO Class 5 aseptic conditions.
-
1
0.1 µm Pre-filtration I — Large Particulate Removal
Removes large aggregates; protects downstream 0.04 µm membranes.
-
2
0.04 µm Pre-filtration II — Mycoplasma Barrier
Retains mycoplasma (0.1–0.3 µm) — absent from standard 0.22 µm filtration.
-
3
0.1 µm Sterile-filtration I — Second-pass Redundancy
Second-pass sterility redundancy; no breakthrough from Stage 1.
-
4
0.04 µm Sterile-filtration II — Final Polish
Ultimate sub-mycoplasma polish; ISO Class 5 aseptic fill & finish.
Performance vs. conventional media
FluxMPS™ DCP-LL15H-P2X delivers approximately 5× lower particulate counts than standard 0.22 µm filtered Leibovitz's, with confirmed mycoplasma barrier at every production stage.
© Diagnocine® — DCP-LL15H-P2X
CO₂-free live imaging and primary cell applications
FluxMPS™ DCP-LL15H-P2X — Leibovitz's L-15 2X + 50mM HEPES — delivers 0.04 µm filtered purity for Primary cells and related OoC applications.
Automated Bioreactors & Robotics
Optional 0.01 µm (10 nm) ultra-filtered variant available on request.
- Total Particulate Exclusion: 10 nm filtration removes nanoparticulate aggregates
- Valve & Sensor Protection: Eliminates micro-fouling in automated perfusion systems
- Extended Perfusion Stability: Consistent nutrient delivery over long-duration culture
Inquiry Required: Contact support@diagnocine.com for the 0.01 µm variant.
Open-Stage & CO₂-Free Microscopy
L-15 + galactose maintains pH without CO₂ — the standard base for prolonged live-cell confocal, TIRF, light-sheet, and spinning disk imaging on open-stage microscopes.
Primary Cell Dissociation & Transport
CO₂-free L-15 is the standard dissociation and transport buffer for primary cells, tissue pieces, and organoids outside the incubator.
OoC Loading & Priming
CO₂-independent L-15 enables chip loading, priming, and cell seeding outside incubators without pH drift during the critical chip assembly steps.
In Vivo Imaging & Intravital Microscopy
L-15 is the standard superfusion medium for intravital microscopy, maintaining pH in open tissue preparations without CO₂ during surgical and imaging procedures.
CO₂-Free Metabolic Studies
Galactose-based energy source enables metabolic studies without CO₂ interference. Galactose forces OXPHOS in metabolically flexible cells.
Acute Brain Slice & Neuron Imaging
CO₂-free L-15 maintains neuronal viability in acute brain slice preparations and dissociated neuron imaging without requiring carbogen (95% O₂/5% CO₂) gassing.
Analytical release specifications
Every lot released against the full specification matrix. CoA: support@diagnocine.com.
| Parameter | Specification |
|---|---|
| Formulation | [+] 1.8 g/L D-Galactose, [+] L-Glutamine, [+] 50mM HEPES | [-] Sodium Pyruvate |
| Appearance | Orange-Red colored, clear solution |
| Carbon source | D-Galactose: 1800 mg/L (1.8 g/L, D-Galactose) |
| HEPES | 50 mM (pKa 7.3 at 37°C) |
| pH USP <791> | 7.4 |
| Osmolality USP <785> | Contact for specification |
| Total ingredients | 35 |
| Parameter | Specification |
|---|---|
| Endotoxin USP <85> BET | < 0.05 EU/mL |
| Sterility USP <71> | No growth / 14 days |
| Mycoplasma | Negative (0.04 µm barrier) |
| Particulate ≥10 µm USP <788> | NMT 25/mL |
| Particulate ≥25 µm USP <788> | NMT 3/mL |
| Water purity | Type 1, 18.2 MΩ·cm |
| Manufacturing std. | ISO 13485:2016 |
| Fill environment | ISO Class 5 (Class 100) |
| Parameter | Specification |
|---|---|
| Storage temperature | 2–8°C, away from light |
| Freeze-thaw | Do not freeze |
| Shelf life | 12 months from manufacture |
| Shipping condition | cold pack |
| CO₂ requirement | CO₂-independent by design — Leibovitz's L-15 uses galactose and high amino acid buffering for CO₂-free pH maintenance. No gas supplementation required. |
| Parameter | Specification |
|---|---|
| Raw material grade | Reagent / cell culture grade |
| Traceability | Full lot traceability per ISO 13485 |
| Manufacturing QMS ISO | ISO 13485:2016 certified |
| Regulatory alignment | 21 CFR Part 820 (cGMP) aligned |
| Production method | Micro-batch, per-lot QC release |
| Intended use | Research Use Only (RUO) |
Full composition (mg/L)
Leibovitz's L-15 2X + 50mM HEPES: 35 ingredients verified per lot with CAS numbers for full raw-material traceability. Leibovitz's L-15 uses D-galactose (not glucose) as the primary carbon source and high amino acid concentrations for CO₂-free pH buffering. This is a 2X concentrated formulation. 50 mM HEPES provides enhanced pH buffering for prolonged open-stage procedures.
| Component | CAS Number | mg/L |
|---|---|---|
| INORGANIC SALTS | ||
| Calcium chloride dihydrate | 10035-04-8 | 370.000 |
| Magnesium chloride hexahydrate | 7791-18-6 | 400.000 |
| Magnesium sulphate anhydrous | 7487-88-9 | 195.440 |
| Potassium chloride | 7447-40-7 | 800.000 |
| Potassium phosphate monobasic | 7778-77-0 | 120.000 |
| Sodium chloride | 7647-14-5 | 16000.000 |
| Sodium dihydrogen phosphate anhydrous | 7558-80-7 | 380.240 |
| Component | CAS Number | mg/L |
|---|---|---|
| AMINO ACIDS | ||
| L-Alanine | 56-41-7 | 450.000 |
| Glycine | 56-40-6 | 400.000 |
| L-Arginine (free base) | 74-79-3 | 1000.000 |
| L-Asparagine | 70-47-3 | 500.000 |
| L-Cysteine (free base) | 52-90-4 | 240.000 |
| L-Glutamine | 56-85-9 | 600.000 |
| L-Histidine (free base) | 71-00-1 | 500.000 |
| L-Isoleucine | 73-32-5 | 500.000 |
| L-Leucine | 61-90-5 | 250.000 |
| L-Lysine hydrochloride | 657-27-2 | 188.000 |
| L-Methionine | 63-68-3 | 150.000 |
| L-Phenylalanine | 63-91-2 | 250.000 |
| L-Serine | 56-45-1 | 400.000 |
| L-Threonine | 72-19-5 | 600.000 |
| L-Tryptophan | 73-22-3 | 40.000 |
| L-Tyrosine disodium salt | 69847-45-6 | 552.320 |
| L-Valine | 72-18-4 | 200.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| VITAMINS | ||
| Choline chloride | 67-48-1 | 2.000 |
| D-Ca-Pantothenate | 137-08-6 | 2.000 |
| Folic acid | 59-30-3 | 2.000 |
| Nicotinamide | 98-92-0 | 2.000 |
| Pyridoxine hydrochloride | 58-56-0 | 2.000 |
| Riboflavin-5-phosphate sodium salt | 130-40-5 | 0.200 |
| Thiamine hydrochloride | 67-03-8 | 2.000 |
| i-Inositol | 87-89-8 | 4.000 |
| OTHERS | ||
| D-Galactose | 59-23-4 | 1800.000 |
| HEPES buffer | 7365-45-9 | 11915.000 |
| Phenol red sodium salt | 34487-61-1 | 22.000 |
Manufacturing & compliance
Every FluxMPS™ product manufactured and released under a rigorous multi-layer quality system.
ISO 13485:2016 Quality Management
Manufactured under ISO 13485:2016–certified and CE-approved facilities. Final QA at DiagnoCine R&D Center, Totowa, NJ, USA.
Ultrapure Type 1 Water
18.2 MΩ·cm — eliminates ionic contaminants.
ISO Class 5 Fill & Finish
Aseptic fill in validated ISO Class 5 (Class 100) laminar-flow workstations.
Micro-Batch Precision
Small-batch, per-lot tested — no blending, Certificate of Analysis for every lot.
Endotoxin — USP <85> BET
LAL assay < 0.05 EU/mL per lot.
Particulate — USP <788> Method 2
≤25/mL (≥10 µm), ≤3/mL (≥25 µm).
Osmolality — USP <785>
Target: Contact for specification.
Documentation & CoA
Full CoA with raw-material traceability available on request.
How DCP-LL15H-P2X compares
FluxMPS™ DCP-LL15H-P2X vs. conventional 0.22 µm–filtered Leibovitz's formulations.
| Parameter | DCP-LL15H-P2X (FluxMPS™) | Conventional Leibovitz's L-1 (0.22 µm filtered) |
Standard DMEM/RPMI (0.22 µm filtered) |
|---|---|---|---|
| L-15 2X + 50mM HEPES — no Pyruvate; researcher-defined secondary carbon with enhanced pH buffering | check_circle Yes | cancel No | cancel No |
| Final filtration pore size | 0.04 µm | 0.22 µm | 0.22 µm |
| Number of filtration stages | 4 (Quadruple) | 1 | 1 |
| Mycoplasma barrier | check_circle Yes (0.04 µm) | cancel No | cancel No |
| CO₂-free design | check_circle Yes (galactose) | check_circle Yes | cancel No |
| HEPES (50 mM) | check_circle Yes | cancel Usually no | cancel No |
| Endotoxin specification | < 0.05 EU/mL | NMT 1 EU/mL | NMT 1 EU/mL |
| USP <788> particulate tested | check_circle Yes | cancel No | cancel No |
| Water quality | Type 1, 18.2 MΩ·cm | Purified water | Purified water |
| Manufacturing QMS | ISO 13485:2016 | ISO 9001 or none | ISO 9001 or none |
| Microfluidic channel compatible | check_circle MPS-grade | cancel Risk of clogging | cancel Risk of clogging |
Frequently asked questions
Common questions about FluxMPS™ DCP-LL15H-P2X — Leibovitz's L-15 2X + 50mM HEPES.
Supporting literature
Key publications supporting Leibovitz's L-15 2X + 50mM HEPES in CO₂-free live-cell imaging, primary cell culture, and OoC applications.
- Leibovitz A. The growth and maintenance of tissue-cell cultures in free gas exchange with the atmosphere. Am J Hyg. 1963;78:173–180. doi:10.1083/jcb.1.3.273
- Huh D, et al. Reconstituting organ-level lung functions on a chip. Science. 2010;328:1662–1668. doi:10.1126/science.1188302
- Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32:760–772. doi:10.1038/nbt.2989
- Novak R, et al. Robotic fluidic coupling and interrogation of multiple vascularized organ chips. Nat Biomed Eng. 2020;4:407–420. doi:10.1038/s41551-019-0497-x
- Jang KJ, et al. Human kidney proximal tubule-on-a-chip. Integr Biol. 2013;5:1119–1129. doi:10.1039/c3ib40049b
- Schimek K, et al. Integrating biological vasculature into a multi-organ-chip microsystem. Lab Chip. 2013;13:3588–3598. doi:10.1039/c3lc50217a
- Luni C, et al. High-efficiency cellular reprogramming with microfluidics. Nat Methods. 2016;13:446–452. doi:10.1038/nmeth.3832
- Sung JH, et al. Microfabricated mammalian organ systems. Lab Chip. 2013;13:1201–1212. doi:10.1039/c3lc41017j


